ACE2 has been found to decrease the transcriptional levels of genes associated with the EMT in vitro, and exposing cells to DX600, an inhibitor of ACE2, recovers the sensitivity of lung cancer cells to TGF-β1 (Qian et al., 2013). Here, ACE2 is linked to lung cancer.